A Multicenter Phase II Trial of mFOLFOX6 Plus Bevacizumab to Treat Liver-Only Metastases of Colorectal Cancer that are Unsuitable for Upfront Resection (TRICC0808)

被引：0
作者：
Hiroyuki Uetake
Masamichi Yasuno
Megumi Ishiguro
Shingo Kameoka
Yasuhiro Shimada
Keiichi Takahashi
Toshiaki Watanabe
Kei Muro
Hideo Baba
Junji Yamamoto
Nobuyuki Mizunuma
Hiroshi Tamagawa
Izumi Mochizuki
Yusuke Kinugasa
Takashi Kikuchi
Kenichi Sugihara
机构：
[1] Tokyo Medical and Dental University,Department of Translational Oncology, Graduate School
[2] Tokyo Metropolitan Hiroo Hospital,Department of Surgery
[3] Tokyo Women’s Medical University,Department of Surgery II
[4] National Cancer Center Hospital,Division of Gastrointestinal Medical Oncology
[5] Tokyo Metropolitan Cancer and Infectious Disease Center,Colorectal Surgical Division, Department of Surgery
[6] Komagome Hospital,Department of Surgical Oncology, Graduate School of Medicine
[7] The University of Tokyo,Clinical Oncology
[8] Aichi Cancer Center Hospital,Department of Gastroenterological Surgery, Graduate School of Medical Science
[9] Kumamoto University,Department of Surgery
[10] National Defense Medical College,Gastroenterological Center
[11] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Surgery
[12] Osaka General Medical Center,Department of Surgery
[13] Iwate Prefectural Central Hospital,Gastrointestinal Surgery Division
[14] Shizuoka Cancer Center,Department of Statistical Analysis
[15] Translational Research Informatics Center,Department of Surgery Oncology
[16] Tokyo Medical and Dental University,undefined
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Bevacizumab; Liver Metastasis; Sixth Cycle; Resectable Liver Metastasis; High Adverse Event;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：908 / 915
页数：7
相关论文
共 35 条
[31]   Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study [J].
Nagasaka, Takeshi ;
Mishima, Hideyuki ;
Sawaki, Akira ;
Shimokawa, Mototsugu ;
Inukai, Michio ;
Shinozaki, Katsunori ;
Tanioka, Hiroaki ;
Nasu, Junichiro ;
Nishina, Tomohiro ;
Hazama, Shoichi ;
Okajima, Masazumi ;
Yamaguchi, Yoshiyuki .
BMJ OPEN, 2016, 6 (06)
[32]   Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial [J].
Chen, Hong-Hwa ;
Lin, Jen-Kou ;
Chen, Joe-Bin ;
Chuang, Chieh-Han ;
Liu, Mei-Ching ;
Wang, Jen-Yi ;
Changchien, Chung-Rong .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (01) :61-68
[33]   Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201 [J].
Takahashi, Shin ;
Ouchi, Kota ;
Sakamoto, Yasuhiro ;
Mori, Takahiro ;
Shimodaira, Hideki ;
Takahashi, Masahiro ;
Ohori, Hisatsugu ;
Kudo, Chieko ;
Takahashi, Yoshikazu ;
Imai, Hiroo ;
Akiyama, Shoko ;
Takahashi, Masanobu ;
Suto, Takeshi ;
Murakawa, Yasuko ;
Oishi, Takayuki ;
Isobe, Hideki ;
Okada, Yoshinari ;
Kawai, Sadayuki ;
Yoshioka, Takashi ;
Sato, Toshihiko ;
Shindo, Yoshiaki ;
Sugiyama, Shunsuke ;
Komine, Keigo ;
Chiba, Natsuko ;
Okita, Akira ;
Yamaguchi, Takuhiro ;
Ishioka, Chikashi .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (02) :676-691
[34]   Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer [J].
Sommerhaeuser, G. ;
Kurreck, A. ;
Stintzing, S. ;
Heinemann, V ;
von Weikersthal, L. Fischer ;
Dechow, T. ;
Kaiser, F. ;
Karthaus, M. ;
Schwaner, I ;
Fuchs, M. ;
Koenig, A. ;
Roderburg, C. ;
Hoyer, I ;
Quante, M. ;
Kiani, A. ;
Fruehauf, S. ;
Mueller, L. ;
Reinacher-Schick, A. ;
Ettrich, T. J. ;
Stahler, A. ;
Modest, D. P. .
BMC CANCER, 2022, 22 (01)
[35]   Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer [J].
G. Sommerhäuser ;
A. Kurreck ;
S. Stintzing ;
V. Heinemann ;
L. Fischer von Weikersthal ;
T. Dechow ;
F. Kaiser ;
M. Karthaus ;
I. Schwaner ;
M. Fuchs ;
A. König ;
C. Roderburg ;
I. Hoyer ;
M. Quante ;
A. Kiani ;
S. Fruehauf ;
L. Müller ;
A. Reinacher-Schick ;
T. J. Ettrich ;
A. Stahler ;
D. P. Modest .
BMC Cancer, 22
1234